mefloquine has been researched along with sphingosine 1-phosphate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dagan, A; Flescher, E; Gatt, S; Gold, D; Pankova-Kholmyansky, I; Skutelsky, E; Zaslavsky, Z | 1 |
| Kelley, M; Li, L; Vessey, DA | 1 |
2 other study(ies) available for mefloquine and sphingosine 1-phosphate
| Article | Year |
|---|---|
Ceramide mediates growth inhibition of the Plasmodium falciparum parasite.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Artemisinins; Ceramides; Glutathione; Growth Inhibitors; Lysophospholipids; Malaria, Falciparum; Mefloquine; Plasmodium falciparum; Sesquiterpenes; Sphingomyelin Phosphodiesterase; Sphingosine | 2003 |
Pannexin-I/P2X 7 purinergic receptor channels mediate the release of cardioprotectants induced by ischemic pre- and postconditioning.
Topics: Adenosine; Adenosine Triphosphate; Animals; Carbenoxolone; Connexins; Ischemic Preconditioning, Myocardial; Lysophospholipids; Mefloquine; Myocardial Reperfusion Injury; Nerve Tissue Proteins; Purinergic P2 Receptor Antagonists; Rats; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Rosaniline Dyes; Sphingosine | 2010 |